| 【Company Research】Giant Biogene (2367 HK) - Recovery expected in 2026E |
| 【Company Research】China Hongqiao (1378 HK) - 2025 core profit in-line; Supply disruption to drive ASP in 2026E |
| 【Company Research】Tuhu Car (9690 HK) - A beneficiary from industry consolidation |
| 【Company Research】VSTECS (856 HK) - FY25 review: AI compute and self-developed products maintain strong momentum |
| 【Company Research】Chuangxin Industries (2788 HK) - Takeaways from post-results meeting |
| 【Company Research】Dmall Inc (2586 HK) - FY25 review: investing in AI to drive dual growth in revenue and profitability |
| 【Company Research】Alibaba (BABA US) - Recovery of consumption business in sight with determined long-term goal for cloud |
| 【Company Research】Xiaomi (1810 HK) - Key takeaways of new-gen SU7 and new MiMo-V2 model releases |
| 【行业研究】医药 - 海外CXO/生命科学上游4Q25/2025业绩剖析：早研需求现复苏端倪，2026年业绩指引偏谨慎 |
| 【Company Research】Horizon Robotics (9660 HK) - High growth potential with unique positioning |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
